Trial ID or NCT#

NCT02424955

Status

recruiting iconRECRUITING

Purpose

The purpose of this study is to prospectively analyze the value of 3D ultrasound perfusion imaging for treatment planning, the prediction of therapy success, and to monitor the treatment response in patients with a primary or metastatic liver tumor undergoing radiation treatment.

Official Title

Feasibility of 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Daniel Chang
Daniel Chang
Radiation oncologist
Sue and Bob McCollum Professor
Aya Kamaya, MD
Aya Kamaya, MD
Radiologist
Professor of Radiology (Body Imaging)
Dimitre Hristov

Contact us to find out if this trial is right for you.

CONTACT

Jen-Yeu Wang
(650) 723-3110